
Opinion|Videos|January 31, 2025
Step-Up Dosing Protocols and Infection Prevention Strategies for Bispecifics in B-Cell Lymphomas
Panelists discuss how step-up dosing protocols reduce cytokine release syndrome (CRS) risk in patients with high-risk disease and when modifications might be necessary as well as the incorporation of infection prevention strategies, including prophylactic antimicrobials, into management plans.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do step-up dosing protocols reduce CRS risk in patients with high-risk disease, and when might you modify this approach? (Dr Allan)
- How do you incorporate infection prevention strategies, such as prophylactic antimicrobials, into your management plans? (Dr Graff)
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Top 5 Most-Read Multiple Sclerosis Articles of 2025
2
2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA
3
Top 5 Trending FDA Approvals of 2025
4
Long-Term Trial Shows Durable Efficacy, QOL Gains With Nirogacestat in Desmoid Tumors
5






































